Kolexia
Patsouris Anne
Oncologie médicale
Ico - Site Paul Papin
Angers, France
123 Activités
506 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Métastase tumorale Tumeurs du sein triple-négatives Tumeurs de l'ovaire Tumeur du sein de l'homme Carcinome épithélial de l'ovaire Carcinomes Récidive tumorale locale Anémie

Industries

Pfizer
6 collaboration(s)
Dernière en 2023
Lilly
4 collaboration(s)
Dernière en 2022
Clovis Oncology
3 collaboration(s)
Dernière en 2022
AstraZeneca
3 collaboration(s)
Dernière en 2023

Dernières activités

p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane.
British journal of cancer   05 janvier 2024
First-line real-world treatment patterns and survival outcomes in women younger or older than 40 years with metastatic breast cancer in the real-life multicenter French ESME cohort.
European journal of cancer (Oxford, England : 1990)   10 novembre 2023
Intrathecal Catheter for Chemotherapy in Leptomeningeal Carcinomatosis From HER2-Negative Metastatic Breast Cancer.
Journal of breast cancer   08 septembre 2023
TRAK-ER: A Randomised Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer
Essai Clinique (Invitae Corporation)   24 août 2023
Atezolizumab and paclitaxel as first line therapy in advanced triple-negative breast cancer patients included in the French early access program.
Scientific reports   18 août 2023
EPICURE_SEIN: Prediction in Silico of Overall Survival in a Pilot Prospective Cohort Study of Metastatic Breast Cancer Patients
Essai Clinique (Lilly)   31 juillet 2023
SKYPE2: A Randomized, Open-labelled, Controlled Trial Evaluating the Efficacy of a Physical Therapy-yoga-patient Educational Program for Breast Cancer Patients With Pain Due to Hormonal Therapy Treatment.
Essai Clinique (Institut du Cancer de Montpellier)   06 juin 2023
Evaluating everolimus for the treatment of breast cancer.
Expert opinion on pharmacotherapy   18 mai 2023
Efficacy of front-line treatment for hormone receptor-positive HER2-negative metastatic breast cancer with germline BRCA1/2 mutation.
British journal of cancer   03 avril 2023
ESME-MBC: Epidemiological Strategy and Medical Economic (ESME) Research Program / Academic Real World Data Platform: Evolution of the Therapeutic Care in Metastatic Breast Cancer Across the French Comprehensive Cancer Centers From 2008
Essai Clinique (Seagen)   16 mars 2023